Intersect Ent Inc. has received approval from the FDA for the Propel Contour steroid releasing sinus implant. The Menlo Park, Calif.-based company’s device treats patients with chronic sinusitis in the frontal and maxillary sinuses
Intersect Ent Inc. has received approval from the FDA for the Propel Contour steroid releasing sinus implant. The Menlo Park, Calif.-based company’s device treats patients with chronic sinusitis in the frontal and maxillary sinuses